4

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: May 13, 2024
Period of Report: May 13, 2024
Accession Number: 0001127602-24-015083

View Document ↗ View on SEC.gov ↗